BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2025 12:56:07 PM | Browse: 168 | Download: 554
 |
Received |
|
2025-04-01 15:06 |
|
Peer-Review Started |
|
2025-04-01 15:06 |
|
First Decision by Editorial Office Director |
|
2025-04-16 10:22 |
|
Return for Revision |
|
2025-04-16 10:22 |
|
Revised |
|
2025-04-30 16:11 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-06-19 02:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-06-19 06:32 |
|
Articles in Press |
|
2025-06-19 06:32 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-07-02 02:23 |
|
Publish the Manuscript Online |
|
2025-07-14 12:56 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Correlation of radiotherapy, targeted therapy, and immunotherapy with hepatocellular carcinoma recurrence
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Qian-Jia Liu, Jia-Cheng Zhang, Yue-Fan Wang, Ming-Hao Zou, Wen-Xuan Zhou, Yan Lu, Xiao-Chen Feng and Hui Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 82270634 |
| Third Affiliated Hospital of Naval Medical University |
No. tf2024yzyy01 |
|
| Corresponding Author |
Hui Liu, The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, No. 225 Changhai Road, Shanghai 200082, China. liuhuigg@hotmail.com |
| Key Words |
Hepatocellular carcinoma; Tumor recurrence; Radiotherapy; Targeted Therapy; Immunotherapy; Treatment strategies |
| Core Tip |
Hepatocellular carcinoma (HCC) is a prevalent cancer worldwide, ranking as the third leading cause of cancer-related deaths. Despite advancements in treatment modalities, a significant proportion of patients with HCC (50%-70%) experience tumor recurrence within 5 years of initial treatment. This review focuses on the roles of radiotherapy, targeted therapy, and immunotherapy in managing post-surgical HCC recurrence and their combined effects. |
| Publish Date |
2025-07-14 12:56 |
| Citation |
Liu QJ, Zhang JC, Wang YF, Zou MH, Zhou WX, Lu Y, Feng XC, Liu H. Correlation of radiotherapy, targeted therapy, and immunotherapy with hepatocellular carcinoma recurrence. World J Gastrointest Oncol 2025; 17(7): 107815 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i7/107815.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i7.107815 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
